NovoCure Ltd. (NVCR)
14.99
-0.21
(-1.38%)
USD |
NASDAQ |
Oct 06, 16:00
14.99
0.00 (0.00%)
After-Hours: 19:51
NovoCure Free Cash Flow : -25.43M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -25.43M |
| March 31, 2026 | -48.07M |
| December 31, 2025 | -75.68M |
| September 30, 2025 | -65.17M |
| June 30, 2025 | -80.40M |
| March 31, 2025 | -72.14M |
| December 31, 2024 | -69.22M |
| September 30, 2024 | -78.21M |
| June 30, 2024 | -104.47M |
| March 31, 2024 | -120.97M |
| December 31, 2023 | -100.43M |
| September 30, 2023 | -89.19M |
| June 30, 2023 | -45.90M |
| March 31, 2023 | -4.605M |
| December 31, 2022 | 9.43M |
| September 30, 2022 | 19.70M |
| June 30, 2022 | 24.08M |
| March 31, 2022 | 36.01M |
| December 31, 2021 | 58.59M |
| September 30, 2021 | 106.18M |
| June 30, 2021 | 113.26M |
| March 31, 2021 | 99.14M |
| Date | Value |
|---|---|
| December 31, 2020 | 84.18M |
| September 30, 2020 | 40.36M |
| June 30, 2020 | 24.38M |
| March 31, 2020 | 21.62M |
| December 31, 2019 | 16.14M |
| September 30, 2019 | 27.25M |
| June 30, 2019 | 19.34M |
| March 31, 2019 | 3.715M |
| December 31, 2018 | -8.576M |
| September 30, 2018 | -28.44M |
| June 30, 2018 | -31.93M |
| March 31, 2018 | -30.09M |
| December 31, 2017 | -40.50M |
| September 30, 2017 | -52.78M |
| June 30, 2017 | -91.90M |
| March 31, 2017 | -120.79M |
| December 31, 2016 | -125.26M |
| September 30, 2016 | -137.37M |
| June 30, 2016 | -123.71M |
| March 31, 2016 | -113.85M |
| December 31, 2015 | -110.16M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Smith & Nephew plc | 849.38M |
| LivaNova Plc | 148.30M |
| Tristel Plc | 12.32M |
| EKF Diagnostics Holdings Plc | 6.561M |
| Niox Group Plc | 15.96M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 8.132M |
| Cash from Investing (Quarterly) | -6.378M |
| Cash from Financing (Quarterly) | 4.548M |
| Free Cash Flow Per Share (Quarterly) | 0.0105 |
| Free Cash Flow to Equity (Quarterly) | 2.736M |
| Free Cash Flow to Firm (Quarterly) | 3.593M |
| Free Cash Flow Yield | -1.49% |